Keyword Analysis & Research: crest trial inclusion criteria
Keyword Research: People who searched crest trial inclusion criteria also searched
Search Results related to crest trial inclusion criteria on Search Engine
Carotid Revascularization and Medical Management for ...
General Inclusion Criteria. Patients ≥35 years old. Carotid stenosis defined as: ... Actively participating in another drug or aortic arch or cerebrovascular device trial for which participation in CREST-2 would be compromised with regard to follow-up assessment of outcomes or continuation in CREST-2.
DA: 100 PA: 12 MOZ Rank: 16
The CREST-2 Registry | National Institute of Neurological ...
Inclusion Criteria Asymptomatic patients: Age ≥ 18 and ≤ 80 and any one of the following 1. ≥70% stenosis, standard surgical risk for CEA 2. ≥70% stenosis, high anatomic risk for CEA 3. ≥70% stenosis, high physiologic risk for CEA Symptomatic patients: Symptomatic patients are defined by the following characteristics: Ipsilateral carotid Transient Ischemic Attack (TIA), with ...
DA: 29 PA: 7 MOZ Rank: 95
CREST 2 Asymptomatic Carotid Stenosis Study | Cedars-Sinai
Please see complete list of inclusion and exclusion criteria. Full Study Name. Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) Protocol (IRB no. 39002) Summary.
DA: 22 PA: 42 MOZ Rank: 31
CREST - Wiki Journal Club
CREST initially sought to enroll only symptomatic patients, but the eligibility criteria were amended in 2005 to allow asymptomatic patients with slightly different criteria for degree of stenosis. Ultimately the study enrolled 2,502 patients with carotid artery stenosis and randomized patients to either stenting or CEA.
DA: 51 PA: 14 MOZ Rank: 49
CREST-2: Identifying the Best Method of Stroke Prevention ...
CREST-2 trial (Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial) is an ambitious attempt to further refine the treatment of asymp-tomatic carotid stenosis. Advances in Revascularization for Acute Ischemic Stroke As one of the largest randomized stroke prevention trials,
DA: 73 PA: 44 MOZ Rank: 1
ISRCTN - ISRCTN54834267: The CReST2 Trial: Are uncovered ...
Participant inclusion criteria. 1. Patients aged 16 year and over 2. Patients presenting with obstructing colorectal cancer, which is to be treated with palliative intent 3. Patients able and willing to give written informed consent
DA: 52 PA: 49 MOZ Rank: 22
CReST2 - All you need to know... • Diagmed Healthcare
CReST2 is an additional study building on the success of CReST – the world’s largest stenting trial of large bowel obstruction! The randomised trial is testing the stated hypothesis of ‘Uncovered vs covered endoluminal stenting in the acute management of obstructing colorectal cancer in the palliative setting’.
DA: 53 PA: 61 MOZ Rank: 65
Stenting versus Endarterectomy for Treatment of Carotid ...
CREST is a randomized, controlled trial with blinded end-point adjudication. Ethics review boards at all participating centers approved the protocol. All patients provided written informed consent.
DA: 86 PA: 99 MOZ Rank: 34